{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:40:26Z","timestamp":1790973626882,"version":"4.1.0"},"reference-count":45,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,11,1]]},"abstract":"<jats:p>OBJECTIVES. Erythropoietin is frequently administered to premature infants to stimulate erythropoiesis. The primary goal of erythropoietin therapy is to reduce transfusions, but the efficacy of erythropoietin has not been convincingly demonstrated in this regard. The aim of this trial was to investigate whether combined administration of vitamin B12, folic acid, iron, and erythropoietin could decrease transfusion requirements in extremely low birth weight infants.<\/jats:p><jats:p>PATIENTS AND METHODS. In a randomized, controlled trial, extremely low birth weight infants with a birth weight \u2264800g and a gestational age \u226432 weeks were randomly assigned to a group receiving combination treatment or a control arm.<\/jats:p><jats:p>RESULTS. The treatment increased levels of folate in red blood cells, vitamin B12, ferritin, transferrin receptor levels in plasma, and reticulocyte counts. The proportion of infants requiring no transfusions was lower in the treatment group (38%) as compared with controls (5%). The treatment group and the need for mechanical ventilation were independent predictors of the number of transfusions in multiple regression analysis. Cox regression analysis indicated that combined therapy resulted in a 79% risk reduction for any transfusion.<\/jats:p><jats:p>CONCLUSION. Combined treatment with erythropoietin, intravenous iron, folate, and vitamin B12 during the first weeks reduces the need for transfusion in extremely low birth weight infants.<\/jats:p>","DOI":"10.1542\/peds.2006-1113","type":"journal-article","created":{"date-parts":[[2006,11,2]],"date-time":"2006-11-02T18:04:44Z","timestamp":1162490684000},"page":"2004-2013","source":"Crossref","is-referenced-by-count":45,"title":["Effects of a Combined Therapy of Erythropoietin, Iron, Folate, and Vitamin B12 on the Transfusion Requirements of Extremely Low Birth Weight Infants"],"prefix":"10.1542","volume":"118","author":[{"given":"Nadja","family":"Haiden","sequence":"first","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Schwindt","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cardona","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Berger","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Klebermass","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wald","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Kohlhauser-Vollmuth","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Jilma","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"Pollak","sequence":"additional","affiliation":[{"name":"Division of Neonatology and Intensive Care, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,11,1]]},"reference":[{"key":"2021120823221012000_R1","doi-asserted-by":"crossref","unstructured":"Ohls RK. Human recombinant erythropoietin in the prevention and treatment of anemia of prematurity. Paediatr Drugs.\u20082002;4:111\u2013121","DOI":"10.2165\/00128072-200204020-00004"},{"key":"2021120823221012000_R2","doi-asserted-by":"crossref","unstructured":"Widness JA, Pathophysiology, diagnosis and prevention of neonatal anaemia. NeoReviews.\u20082000;1:e61\u2013e69","DOI":"10.1542\/neo.1-4-e61"},{"key":"2021120823221012000_R3","doi-asserted-by":"crossref","unstructured":"Shannon KM, Keith JF, 3rd, Mentzer WC, et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics.\u20081995;95:1\u20138","DOI":"10.1542\/peds.95.1.1"},{"key":"2021120823221012000_R4","doi-asserted-by":"crossref","unstructured":"Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study. J Pediatr.\u20081997;131:661\u2013665","DOI":"10.1016\/S0022-3476(97)70089-1"},{"key":"2021120823221012000_R5","doi-asserted-by":"crossref","unstructured":"Maier RF, Obladen M, Scigalla P, et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med.\u20081994;330:1173\u20131178","DOI":"10.1056\/NEJM199404283301701"},{"key":"2021120823221012000_R6","doi-asserted-by":"crossref","unstructured":"Maier RF, Obladen M, Kattner E, et al. High-versus low-dose erythropoietin in extremely low birth weight infants. The European Multicenter rhEPO Study Group. J Pediatr.\u20081998;132:866\u2013870","DOI":"10.1016\/S0022-3476(98)70320-8"},{"key":"2021120823221012000_R7","doi-asserted-by":"crossref","unstructured":"Maier RF, Obladen M, Muller-Hansen I, et al. European Multicenter Erythropoietin Beta Study Group. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr.\u20082002;141:8\u201315","DOI":"10.1067\/mpd.2002.124309"},{"key":"2021120823221012000_R8","doi-asserted-by":"crossref","unstructured":"Meyer MP, Meyer JH, Commerford A, et al. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Pediatrics.\u20081994;93:918\u2013923","DOI":"10.1542\/peds.93.6.918"},{"key":"2021120823221012000_R9","doi-asserted-by":"crossref","unstructured":"Donato H, Vain N, Rendo P, et al. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial. Pediatrics.\u20082000;105:1066\u20131072","DOI":"10.1542\/peds.105.5.1066"},{"key":"2021120823221012000_R10","doi-asserted-by":"crossref","unstructured":"Pollak A, Hayde M, Hayn M, et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics.\u20082001;107:78\u201385","DOI":"10.1542\/peds.107.1.78"},{"key":"2021120823221012000_R11","doi-asserted-by":"crossref","unstructured":"Al-Kharfy T, Smyth JA, Wadsworth L, et al. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr.\u20081996;129:89\u201396","DOI":"10.1016\/S0022-3476(96)70194-4"},{"key":"2021120823221012000_R12","doi-asserted-by":"crossref","unstructured":"Vamvakas EC, Strauss RG. Meta-analysis of controlled clinical trials studying the efficacy of rHuEPO in reducing blood transfusions in the anemia of prematurity. Transfusion.\u20082001;41;406\u2013415","DOI":"10.1046\/j.1537-2995.2001.41030406.x"},{"key":"2021120823221012000_R13","doi-asserted-by":"crossref","unstructured":"Kotto-Kome AC, Garcia MG, Calhoun DA, et al. Effect of beginning recombinant erythropoietin treatment within the first week of life, among very-low-birth-weight neonates, on \u201cearly\u201d and \u201clate\u201d erythrocyte transfusions: a meta-analysis. J Perinatol.\u20082004;24;24\u201329","DOI":"10.1038\/sj.jp.7211018"},{"key":"2021120823221012000_R14","doi-asserted-by":"crossref","unstructured":"Garcia MG, Hutson AD, Christensen RD. Effect of recombinant erythropoietin on \u201clate\u201d transfusions in the neonatal intensive care unit: a meta-analysis. J Perinatol.\u20082002;22;108\u2013111","DOI":"10.1038\/sj.jp.7210677"},{"key":"2021120823221012000_R15","doi-asserted-by":"crossref","unstructured":"Strauss RG. Red blood cell transfusion practices in the neonate. Clin Perinatol.\u20081995;22:641\u2013655","DOI":"10.1016\/S0095-5108(18)30273-2"},{"key":"2021120823221012000_R16","doi-asserted-by":"crossref","unstructured":"Ohls RK, Ehrenkranz RA, Wright LL, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics.\u20082001;108:934\u2013942","DOI":"10.1542\/peds.108.4.934"},{"key":"2021120823221012000_R17","doi-asserted-by":"crossref","unstructured":"Ohls RK. Erythropoietin treatment in extremely low birth weight infants: blood in versus blood out. J Pediatr.\u20082002;141;3\u20136","DOI":"10.1067\/mpd.2002.125853"},{"key":"2021120823221012000_R18","doi-asserted-by":"crossref","unstructured":"Neu J, Valentine C, Meetze W. Scientifically-based strategies for nutrition of the high-risk low birth weight infant. Eur J Pediatr.\u20081990;150:2\u201313","DOI":"10.1007\/BF01959470"},{"key":"2021120823221012000_R19","doi-asserted-by":"crossref","unstructured":"Brown MS, Shapiro H. Effect of protein intake on erythropoiesis during erythropoietin treatment of anemia of prematurity. J Pediatr.\u20081996;128:512\u2013517","DOI":"10.1016\/S0022-3476(96)70362-1"},{"key":"2021120823221012000_R20","doi-asserted-by":"crossref","unstructured":"Shojania AM. Folic acid and vitamin B12 deficiency in pregnancy and in the neonatal period. Clin Perinatol.\u20081984;11:433\u2013459","DOI":"10.1016\/S0095-5108(18)30928-X"},{"key":"2021120823221012000_R21","doi-asserted-by":"crossref","unstructured":"Gallagher PG, Ehrenkranz RA. Nutritional anemias in infancy. Clin Perinatol.\u20081995;22:671\u2013692","DOI":"10.1016\/S0095-5108(18)30275-6"},{"key":"2021120823221012000_R22","doi-asserted-by":"crossref","unstructured":"Worthington-White DA, Behnke M, Gross S. Premature infants require additional folate and vitamin B-12 to reduce the severity of the anemia of prematurity. Am J Clin Nutr.\u20081994;60:930\u2013935","DOI":"10.1093\/ajcn\/60.6.930"},{"key":"2021120823221012000_R23","doi-asserted-by":"crossref","unstructured":"Haiden N, Klebermass K, Cardona F, et al. A randomized controlled trial on the effects of adding vitamin B 12 and folate to erythropoietin for the treatment of anemia of prematurity. Pediatrics.\u20082006;118:180\u2013188","DOI":"10.1542\/peds.2005-2475"},{"key":"2021120823221012000_R24","doi-asserted-by":"crossref","unstructured":"Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr.\u20081978;92:529\u2013534","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"2021120823221012000_R25","doi-asserted-by":"crossref","unstructured":"Haiden N, Cardona F, Schwindt J, et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost.\u20082005;93:118\u2013123","DOI":"10.1160\/TH04-02-0093"},{"key":"2021120823221012000_R26","unstructured":"Afzali B, Goldsmith DJ. Intravenous iron therapy in renal failure: friend and foe?J Nephrol.\u20082004;17;487\u2013495"},{"key":"2021120823221012000_R27","doi-asserted-by":"crossref","unstructured":"Sunder-Plassmann G, Patruta SI, Horl WH. Pathobiology of the role of iron in infection. Am J Kidney Dis.\u20081999;34(4 suppl 2):S25\u2013S29","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0025"},{"key":"2021120823221012000_R28","doi-asserted-by":"crossref","unstructured":"Lentze MJ, Schulte FJ, Schaub J, et al. Reference Values by O. Oster. Pa\u0308diatrie, 3rd ed. Berlin, Germany: Springer; 2003:1806","DOI":"10.1007\/978-3-662-09176-0"},{"key":"2021120823221012000_R29","doi-asserted-by":"crossref","unstructured":"Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci.\u20082000;37:93\u2013130","DOI":"10.1080\/10408360091174196"},{"key":"2021120823221012000_R30","doi-asserted-by":"crossref","unstructured":"Emmerson AJ, Coles HJ, Stern CM, et al. Double blind trial of recombinant human erythropoietin in preterm infants. Arch Dis Child.\u20081993;68:291\u2013296","DOI":"10.1136\/adc.68.3_Spec_No.291"},{"key":"2021120823221012000_R31","doi-asserted-by":"crossref","unstructured":"Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood.\u20082000;1;96:823\u2013833","DOI":"10.1182\/blood.V96.3.823"},{"key":"2021120823221012000_R32","doi-asserted-by":"crossref","unstructured":"Juul SE, Zerzan JC, Strandjord TP, et al. Zinc protoporphyrin\/heme as an indicator of iron status in NICU patients. J Pediatr.\u20082003;142:273\u2013278","DOI":"10.1067\/mpd.2003.101"},{"key":"2021120823221012000_R33","doi-asserted-by":"crossref","unstructured":"Miller SM, McPherson RJ, Juul SE. Iron sulfate supplementation decreases zinc protoporphyrin to heme ratio in premature infants. J Pediatr.\u20082006;148:44\u201348","DOI":"10.1016\/j.jpeds.2005.08.052"},{"key":"2021120823221012000_R34","doi-asserted-by":"crossref","unstructured":"Kling PJ, Winzerling JJ. Iron status and the treatment of the anemia of prematurity. Clin Perinatol.\u20082002;29:283\u2013294","DOI":"10.1016\/S0095-5108(02)00002-7"},{"key":"2021120823221012000_R35","doi-asserted-by":"crossref","unstructured":"Lundstrom U, Siimes MA, Dallman PR. At what age does iron supplementation become necessary in low-birth-weight infants?J Pediatr.\u20081977;91:878\u2013883","DOI":"10.1016\/S0022-3476(77)80881-0"},{"key":"2021120823221012000_R36","doi-asserted-by":"crossref","unstructured":"Bader D, Blondheim O, Jonas R, et al. Decreased ferritin levels, despite iron supplementation, during erythropoietin therapy in anaemia of prematurity. Acta Paediatr.\u20081996;85:496\u2013501","DOI":"10.1111\/j.1651-2227.1996.tb14070.x"},{"key":"2021120823221012000_R37","doi-asserted-by":"crossref","unstructured":"Beguin Y, Clemons GK, Pootrakul P, et al. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood.\u20081993;15:1067\u20131076","DOI":"10.1182\/blood.V81.4.1067.bloodjournal8141067"},{"key":"2021120823221012000_R38","doi-asserted-by":"crossref","unstructured":"Kohgo Y, Niitsu Y, Kondo H, et al. Serum transferrin receptor as a new index of erythropoiesis. Blood.\u20081987;70:1955\u20131958","DOI":"10.1182\/blood.V70.6.1955.1955"},{"key":"2021120823221012000_R39","doi-asserted-by":"crossref","unstructured":"Kivivuori SM, Heikinheimo M, Teppo AM, et al. Early rise in serum concentration of transferrin receptor induced by recombinant human erythropoietin in very-low-birth-weight infants. Pediatr Res.\u20081994;36:85\u201389","DOI":"10.1203\/00006450-199407001-00015"},{"key":"2021120823221012000_R40","doi-asserted-by":"crossref","unstructured":"Beguin Y, Loo M, R'Zik S, et al. Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood.\u20081993;82:2010\u20132016","DOI":"10.1182\/blood.V82.7.2010.2010"},{"key":"2021120823221012000_R41","doi-asserted-by":"crossref","unstructured":"Ozer EA, Kumral A, Ozer E, et al. Effects of erythropoietin on hyperoxic lung injury in neonatal rats. Pediatr Res.\u20082005;58:38\u201341","DOI":"10.1203\/01.PDR.0000163391.75389.52"},{"key":"2021120823221012000_R42","doi-asserted-by":"crossref","unstructured":"Ohls RK, Hunter DD, Christensen RD. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia. J Pediatr.\u20081993;123:996\u20131000","DOI":"10.1016\/S0022-3476(05)80401-9"},{"key":"2021120823221012000_R43","doi-asserted-by":"crossref","unstructured":"Brown MS, Baron AE, France EK, et al. Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity. JAAPOS.\u20082006;10:143\u2013149","DOI":"10.1016\/j.jaapos.2005.09.005"},{"key":"2021120823221012000_R44","doi-asserted-by":"crossref","unstructured":"Watanabe D, Suzuma K, Matsui S, et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med.\u20082005;25:782\u2013792","DOI":"10.1056\/NEJMoa041773"},{"key":"2021120823221012000_R45","doi-asserted-by":"crossref","unstructured":"Ledbetter DJ, Juul SE. Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight. J Pediatr Surg.\u20082000;35:178\u2013181","DOI":"10.1016\/S0022-3468(00)90006-X"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/2004\/1117230\/zpe01106002004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/5\/2004\/1117230\/zpe01106002004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T16:33:24Z","timestamp":1683650004000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/5\/2004\/69953\/Effects-of-a-Combined-Therapy-of-Erythropoietin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,1]]},"references-count":45,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2006,11,1]]},"published-print":{"date-parts":[[2006,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-1113","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,1]]}}}